Search research articles
Contact Us
Filters
Showing results (51-60 of 114) with videos related to
Page
of 12
Sort By:
Prostaglandins
|
March 1, 1983
Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with patent ductus arteriosus (PDA)
T F Yeh, D Raval, S Pyati, et al.
Archives of Disease in Childhood
|
July 1, 1985
Renal response to frusemide in preterm infants with respiratory distress syndrome during the first three postnatal days
T F Yeh, D Raval, E John, et al.
The Journal of Pediatrics
|
December 1, 1994
Nebulized furosemide in infants with bronchopulmonary dysplasia
A Rastogi, M Luayon, O A Ajayi, et al.
Journal of the National Medical Association
|
November 5, 1997
Ophthalmological morbidity in very-low-birthweight infants with bronchopulmonary dysplasia
O A Ajayi, D Raval, N Lucheese, et al.
Journal of Pediatric Surgery
|
August 1, 1986
Glucose homeostasis during anesthesia and surgery in infants
G Srinivasan, R Jain, R S Pildes, et al.
Developmental Pharmacology and Therapeutics
|
January 1, 1989
Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels
T F Yeh, B Achanti, H Patel, et al.
Developmental Pharmacology and Therapeutics
|
January 1, 1986
Indomethacin therapy in premature infants with patent ductus arteriosus and oliguria
T F Yeh, A Wilks, J Luken, et al.
Critical Care Medicine
|
September 1, 1982
Lung volume, dynamic lung compliance, and blood gases during the first 3 days of postnatal life in infants with meconium aspiration syndrome
T F Yeh, L D Lilien, A Barathi, et al.
The Journal of Pediatrics
|
April 1, 1981
Decreasing mortality in neonates with early-onset group B streptococcal infection: reality or artifact
S P Pyati, R S Pildes, R S Ramamurthy, et al.
Pediatric Pharmacology (New York, N.Y.)
|
January 1, 1985
Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus
L D Lilien, G Srinivasan, T F Yeh, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 114) with videos related to
Sort By:
Page
of 12
Prostaglandins
|
March 1, 1983
Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with patent ductus arteriosus (PDA)
T F Yeh, D Raval, S Pyati, et al.
Archives of Disease in Childhood
|
July 1, 1985
Renal response to frusemide in preterm infants with respiratory distress syndrome during the first three postnatal days
T F Yeh, D Raval, E John, et al.
The Journal of Pediatrics
|
December 1, 1994
Nebulized furosemide in infants with bronchopulmonary dysplasia
A Rastogi, M Luayon, O A Ajayi, et al.
Journal of the National Medical Association
|
November 5, 1997
Ophthalmological morbidity in very-low-birthweight infants with bronchopulmonary dysplasia
O A Ajayi, D Raval, N Lucheese, et al.
Journal of Pediatric Surgery
|
August 1, 1986
Glucose homeostasis during anesthesia and surgery in infants
G Srinivasan, R Jain, R S Pildes, et al.
Developmental Pharmacology and Therapeutics
|
January 1, 1989
Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels
T F Yeh, B Achanti, H Patel, et al.
Developmental Pharmacology and Therapeutics
|
January 1, 1986
Indomethacin therapy in premature infants with patent ductus arteriosus and oliguria
T F Yeh, A Wilks, J Luken, et al.
Critical Care Medicine
|
September 1, 1982
Lung volume, dynamic lung compliance, and blood gases during the first 3 days of postnatal life in infants with meconium aspiration syndrome
T F Yeh, L D Lilien, A Barathi, et al.
The Journal of Pediatrics
|
April 1, 1981
Decreasing mortality in neonates with early-onset group B streptococcal infection: reality or artifact
S P Pyati, R S Pildes, R S Ramamurthy, et al.
Pediatric Pharmacology (New York, N.Y.)
|
January 1, 1985
Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus
L D Lilien, G Srinivasan, T F Yeh, et al.
Page
of 12